Eisai Inc. [clinicaltrials_resource:73f65fc9612e17a505f490571aa8adc5]
Franklin Johnson [clinicaltrials_resource:071221ba926daf55afd48ab41ef5649d]Yufang Lu [clinicaltrials_resource:0aec9a9377aa1988ae517f9f01f27eea]Erhan Berrak, MD [clinicaltrials_resource:0cd44c473c59924a817e4df33d979ba6]Eisa Inc [clinicaltrials_resource:0ed39378f961bebde355b03a96cdbd15]Akhil Baranwal, MD [clinicaltrials_resource:0f6cce2c756c99df63eb3dce87138be0]Margaret Moline, Ph.D. [clinicaltrials_resource:10ae9a33b013edc8cc264ad59f7d69bd]Erhan Berrak, MD [clinicaltrials_resource:15526b4e6b7d64dd469e7b0e3b0b6333]Santiago Arroyo, M.D., Ph.D. [clinicaltrials_resource:1792ae7e81ac90d6b565092e0005b328]Daniel Stepan [clinicaltrials_resource:1d106d1974aef5cea804c8d928d15b0c]David Squillacote, M.D. [clinicaltrials_resource:1e302925995c74bccbd420ecaa055c8a]James Jones, PharmD, MD [clinicaltrials_resource:1ffed46ebe0f82c4f0a861268e943159]Antonella Favit-Van Pelt, MD, PhD [clinicaltrials_resource:2386579b7a9b9e8be232eebdd876edec]Dale Schuster, Ph.D [clinicaltrials_resource:23ec07977e9115db9b77302cf2ec4a3a]Marco Cyrille, MD [clinicaltrials_resource:246d6c7324bbb0e64c65292992745e0d]Eisai Medical Services [clinicaltrials_resource:2512d74b104887fed945b5e91b9ad3d5]Anita Murthy, PharmD [clinicaltrials_resource:273006a43ec92e65e4e7aaf18010e6e7]MGI Medical Communications [clinicaltrials_resource:32a3327a25f09bdc7996619f34bb3624]Karen Stein [clinicaltrials_resource:38df4789520d3a969af88800da8ec8c4]Tim Jenkins [clinicaltrials_resource:40acb73b2c114102d35feab1978ca7f7]Chad Swanson [clinicaltrials_resource:4143b3dc5a88102f0a3a48845d6f8b20]James Jones, MD, PharmD [clinicaltrials_resource:43f21e166da1d165bc832e3f67dbf02a]Dan Rossignol [clinicaltrials_resource:491457097e3089849d3d01b07611c368]Jantien Wanders, MD [clinicaltrials_resource:4a912ea54338556245f46cbc9172a11b]Robert Shumaker [clinicaltrials_resource:5519b4c6708ced67fa0311374a9a1b73]James Prodafikas, MD [clinicaltrials_resource:558617926e8de630c561886cf74092b1]Anita Murthy [clinicaltrials_resource:5a97e5be9e009f99e6a8884524697033]Julia Young, M.D., Ph.D. [clinicaltrials_resource:5b588f13090c183c121b8c7e5504ae43]Dale Shuster, Ph.D. [clinicaltrials_resource:61f20c91bd75b2dfb58c4e3bd60df447]Larisa Reyderman [clinicaltrials_resource:62e94096a81874a9d7ee6132af461fe2]Jantien Wanders, M.D. [clinicaltrials_resource:66703743ab369fbb3b0fee3736e108e9]Study Director [clinicaltrials_resource:6902bb925d1d411561059126bf856891]Asha Das [clinicaltrials_resource:6accaf83935f37fd64b2220919f7216f]Michael Silverman, MD [clinicaltrials_resource:6d9b847167e5732ea8a7072a9e6268c1]Dr. Bhaskar Rege [clinicaltrials_resource:6e0a72c58f63b93e195edce629d71427]Julia Yang, MD, MBA [clinicaltrials_resource:72c3fd74fd78e935fede2482bd9732f3]Christa Nagy [clinicaltrials_resource:73b5ce7b85aab7607b8468abb2922e02]Randi Fain [clinicaltrials_resource:776d972eaa07978834add36e4434d985]Antonio Laurenza, M. D. [clinicaltrials_resource:7a3948294204f5dc936a3eb822681ac7]Antonio Laurenza, M.D. [clinicaltrials_resource:7e73516b591c7e6de71777fe6eca9912]Pei-Ran Ho, MD [clinicaltrials_resource:83ce7cbcc56fa2e4f9b7fd1da55d35b7]
affiliation [clinicaltrials_vocabulary:affiliation]
Evaluate the Effects of GPI 1485 on Erectile Function Following Bilateral Nerve-Sparing Prostatectomy [clinicaltrials:NCT00090376]Efficacy and Safety of Aricept in the Treatment of Severe Alzheimer's Disease [clinicaltrials:NCT00096473]Effects of Combination Therapy With Alpha-1 Blocker (Bunazosin or Doxazosin) in the Treatment of Patients With Mild to Moderate Essential Hypertension [clinicaltrials:NCT00130156]clinicaltrials:NCT00165672Efficacy and Safety of Donepezil Hydrochloride (Aricept) in Vascular Dementia [clinicaltrials:NCT00165763]2 Year Study to Evaluate the Effects of GPI 1485 on [123I]b-CIT/SPECTScanning and Clinical Efficacy in Patients With PD [clinicaltrials:NCT00209508]Comparison of AQUAVAN® Injection to DISOPRIVAN® Injectable Emulsion for Anesthesia During Coronary Artery Surgery [clinicaltrials:NCT00209521]A Study of AQUAVAN® Injection in the Presence of Pre-Medication in Patients Undergoing Elective Colonoscopy [clinicaltrials:NCT00209534]Study to Assess Safety and Efficacy of AQUAVAN® Injection for Sedation During Cardiac Catheterization [clinicaltrials:NCT00209547]clinicaltrials:NCT00209560A Study of AQUAVAN® Injection Versus Midazolam HCl for Sedation in Patients Undergoing Elective Colonoscopy [clinicaltrials:NCT00209573]A Study of AQUAVAN® Injection for Sedation in Elderly Patients Undergoing Flexible Bronchoscopy [clinicaltrials:NCT00209586]A Study of AQUAVAN® Injection Versus Midazolam HCl for Sedation in Elderly Patients Undergoing Elective Colonoscopy [clinicaltrials:NCT00209599]Study of ONTAK® to Treat Cutaneous T-Cell Lymphoma (CTCL) [clinicaltrials:NCT00211198]EARTH 413: A Study of Aricept in Hispanic Patients With Mild to Moderate Alzheimer's Disease (AD) [clinicaltrials:NCT00230568]clinicaltrials:NCT00246090Study Investigating the Effect of E7337 on Tumor Like Lesions in Computed Tomography (CT) of the Liver [clinicaltrials:NCT00280410]The Evaluation of the Efficacy and Safety of Donepezil Hydrochloride in Subjects With Mild Cognitive Impairment (MCI) [clinicaltrials:NCT00293176]Safety and Efficacy Study for the Prevention of Nausea and Vomiting in Multiple Myeloma Patients Receiving Stem Cell Transplantation. [clinicaltrials:NCT00306735]Evaluation of Eperisone HCl in the Treatment of Acute Musculoskeletal Spasm Associated With Low Back Pain - A Double Blind, Randomised, Placebo Controlled Clinical Trial [clinicaltrials:NCT00327730]clinicaltrials:NCT00388726Post-marketing Study of Monteplase ("Cleactor") in Patients With Acute Pulmonary Embolism [clinicaltrials:NCT00442234]clinicaltrials:NCT00477659clinicaltrials:NCT00478205clinicaltrials:NCT00505284clinicaltrials:NCT00566501Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In Treating Cognitive Dysfunction Exhibited By Children With Down Syndrome [clinicaltrials:NCT00570128]The Effectiveness And Safety Of Donepezil Hydrochloride (E2020) In Subjects With Mild To Severe Alzheimer's Disease Residing In An Assisted Living Facility [clinicaltrials:NCT00571064]ZAGAL Study: Evaluating Effectiveness and Tolerability of Zonisamide as Adjunctive Therapy in Patients With Partial Onset Seizures Treated With Two Antiepileptic Drugs [clinicaltrials:NCT00659958]clinicaltrials:NCT00675025Efficacy and Safety of Donepezil Hydrochloride in Preadolescent and Adolescent Children With Attention Impairment Following Cancer Treatment [clinicaltrials:NCT00688376]Evaluating The Impact Of Donepezil Hydrochloride (Aricept) On Behavioral And Psychological Symptoms In Patients With Severe Alzheimer's Disease [clinicaltrials:NCT00711204]clinicaltrials:NCT00754013clinicaltrials:NCT00754052clinicaltrials:NCT01126736clinicaltrials:NCT01126749clinicaltrials:NCT01127451clinicaltrials:NCT01133756E7080 in Combination With Dacarbazine Versus Dacarbazine Alone as First Line Therapy in Patients With Stage IV Melanoma [clinicaltrials:NCT01133977]clinicaltrials:NCT01133990
collaborator [clinicaltrials_vocabulary:collaborator]
Irofulven Compared With Fluorouracil in Treating Patients With Pancreatic Cancer [clinicaltrials:NCT00033735]A Safety and Efficacy Study of Intravenous E5564 in Patients With Severe Sepsis [clinicaltrials:NCT00046072]clinicaltrials:NCT00050960Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung Cancer [clinicaltrials:NCT00050973]Study of ONTAK (Denileukin Diftitox) in Cutaneous T-Cell Lymphoma (CTCL) Patients [clinicaltrials:NCT00050999]Study of ONTAK (Denileukin Diftitox) in Previously Treated Cutaneous T-Cell Lymphoma Patients [clinicaltrials:NCT00051012]Phase II Study of ONTAK in Previously Treated Patients With Low-grade Non-Hodgkin's Lymphoma (NHL) [clinicaltrials:NCT00051025]Study of ONTAK in Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) [clinicaltrials:NCT00055146]Dose Response Study of Zonegran in Patients With Newly Diagnosed Epilepsy [clinicaltrials:NCT00056576]A Safety, Tolerability and Efficacy Study of E7070 in Patients With Renal Cell Carcinoma [clinicaltrials:NCT00059735]Dose-Finding Study of E7070 in Combination With Irinotecan [clinicaltrials:NCT00060567]clinicaltrials:NCT00069264Study of E7389 Administered Once Every 3 Weeks In Patients With Advanced Solid Tumors [clinicaltrials:NCT00069277]Dosing and Safety Study of E7820 in Patients With a Malignant Solid Tumor or Lymphoma [clinicaltrials:NCT00078637]Study to Evaluate the Efficacy, Safety, and Tolerability of E7070 in Metastatic Breast Cancer Patients [clinicaltrials:NCT00080197]Evaluate the Effects of GPI 1485 on Erectile Function Following Bilateral Nerve-Sparing Prostatectomy [clinicaltrials:NCT00090376]Efficacy and Safety of Aricept in the Treatment of Severe Alzheimer's Disease [clinicaltrials:NCT00096473]clinicaltrials:NCT00097721clinicaltrials:NCT00100932A Phase I/Ib, Multicenter, Open-Label, Dose Escalation Study of E7080 in Patients With Solid Tumors and in Combination With Temozolomide in Patients With Advanced and/or Metastatic Melanoma [clinicaltrials:NCT00121680]An Open Label Phase I Dose Escalation Study Of E7080 [clinicaltrials:NCT00121719]An Open-Label Study of E7974 Administered on Days 1, 8, and 15 of a 28-Day Cycle and Days 1 and 8 of a 21-Day Cycle in Patients With Solid Malignancies [clinicaltrials:NCT00121732]Study of Irofulven Plus Capecitabine in Patients With Advanced Thyroid Cancer [clinicaltrials:NCT00124527]Study of Irofulven in Patients With Hormone-refractory Prostate Cancer [clinicaltrials:NCT00124566]GPI 15715 For Sedation in the Intensive Care Unit (ICU) Setting [clinicaltrials:NCT00125398]Study of AQUAVAN® Injection (AQUAVAN; Fospropofol Disodium) for Sedation During Colonoscopy [clinicaltrials:NCT00125424]Effects of Combination Therapy With Alpha-1 Blocker (Bunazosin or Doxazosin) in the Treatment of Patients With Mild to Moderate Essential Hypertension [clinicaltrials:NCT00130156]A Phase 1 Open-Label Study of E7974 Administered on Days 1 and 15 of a 28-Day Cycle in Patients With Solid Malignancies [clinicaltrials:NCT00130169]clinicaltrials:NCT00132496E2007 Given as Adjunctive Therapy in Patients With Refractory Partial Seizures [clinicaltrials:NCT00144690]clinicaltrials:NCT00154063clinicaltrials:NCT00165672Donepezil Hydrochloride (E2020) in Dementia Associated With Cerebrovascular Disease [clinicaltrials:NCT00165737]Efficacy and Safety of Donepezil Hydrochloride (Aricept) in Vascular Dementia [clinicaltrials:NCT00165763]A Study to Explore the Safety And Tolerability of Doses of E2007 Up to a Maximum of 8 mg In Patients With Parkinson's Disease Who Experience End-of-Dose Wearing Off Motor Fluctuations [clinicaltrials:NCT00165789]A Phase I Open Label Study of E7974 Administered on a Day 1 of 21-Day Cycle In Patients With Advanced Solid Tumors [clinicaltrials:NCT00165802]clinicaltrials:NCT001658412 Year Study to Evaluate the Effects of GPI 1485 on [123I]b-CIT/SPECTScanning and Clinical Efficacy in Patients With PD [clinicaltrials:NCT00209508]Comparison of AQUAVAN® Injection to DISOPRIVAN® Injectable Emulsion for Anesthesia During Coronary Artery Surgery [clinicaltrials:NCT00209521]A Study of AQUAVAN® Injection in the Presence of Pre-Medication in Patients Undergoing Elective Colonoscopy [clinicaltrials:NCT00209534]
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
Eisai Medical Affairs, Eisai Inc. [clinicaltrials_resource:52fdcb1bb9b9611462480c9249a84c7a]Margaret Moline, Ph.D, Study Director, Eisai Inc. [clinicaltrials_resource:8102ddc3c2f7fcc64512f52f8edd0f89]Yvonne Noble, Study Manager, Eisai Inc. [clinicaltrials_resource:b7b8d1efd3c34b3d87dc6827ca83153b]James Prodafikas, Study Director, Eisai Inc. [clinicaltrials_resource:bb3d07152d1aed07bd44bbab4a779587]Eisai Medical Services, Eisai Inc. [clinicaltrials_resource:e391eb3b8f6067a3e4cd7a13e960df6b]
organization [clinicaltrials_vocabulary:organization]
Irofulven Compared With Fluorouracil in Treating Patients With Pancreatic Cancer [clinicaltrials:NCT00033735]A Safety and Efficacy Study of Intravenous E5564 in Patients With Severe Sepsis [clinicaltrials:NCT00046072]clinicaltrials:NCT00050960Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung Cancer [clinicaltrials:NCT00050973]Study of ONTAK (Denileukin Diftitox) in Cutaneous T-Cell Lymphoma (CTCL) Patients [clinicaltrials:NCT00050999]Study of ONTAK (Denileukin Diftitox) in Previously Treated Cutaneous T-Cell Lymphoma Patients [clinicaltrials:NCT00051012]Phase II Study of ONTAK in Previously Treated Patients With Low-grade Non-Hodgkin's Lymphoma (NHL) [clinicaltrials:NCT00051025]Study of ONTAK in Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) [clinicaltrials:NCT00055146]Dose Response Study of Zonegran in Patients With Newly Diagnosed Epilepsy [clinicaltrials:NCT00056576]A Safety, Tolerability and Efficacy Study of E7070 in Patients With Renal Cell Carcinoma [clinicaltrials:NCT00059735]Dose-Finding Study of E7070 in Combination With Irinotecan [clinicaltrials:NCT00060567]clinicaltrials:NCT00069264Study of E7389 Administered Once Every 3 Weeks In Patients With Advanced Solid Tumors [clinicaltrials:NCT00069277]Dosing and Safety Study of E7820 in Patients With a Malignant Solid Tumor or Lymphoma [clinicaltrials:NCT00078637]Study to Evaluate the Efficacy, Safety, and Tolerability of E7070 in Metastatic Breast Cancer Patients [clinicaltrials:NCT00080197]Evaluate the Effects of GPI 1485 on Erectile Function Following Bilateral Nerve-Sparing Prostatectomy [clinicaltrials:NCT00090376]Efficacy and Safety of Aricept in the Treatment of Severe Alzheimer's Disease [clinicaltrials:NCT00096473]clinicaltrials:NCT00097721clinicaltrials:NCT00100932The Efficacy, Safety, And Tolerability Of Donepezil HCl (E2020) In Patients With CADASIL Who Have Cognitive Impairment [clinicaltrials:NCT00103948]A Phase I/Ib, Multicenter, Open-Label, Dose Escalation Study of E7080 in Patients With Solid Tumors and in Combination With Temozolomide in Patients With Advanced and/or Metastatic Melanoma [clinicaltrials:NCT00121680]An Open Label Phase I Dose Escalation Study Of E7080 [clinicaltrials:NCT00121719]An Open-Label Study of E7974 Administered on Days 1, 8, and 15 of a 28-Day Cycle and Days 1 and 8 of a 21-Day Cycle in Patients With Solid Malignancies [clinicaltrials:NCT00121732]Study of Irofulven Plus Capecitabine in Patients With Advanced Thyroid Cancer [clinicaltrials:NCT00124527]Study of Irofulven in Patients With Hormone-refractory Prostate Cancer [clinicaltrials:NCT00124566]GPI 15715 For Sedation in the Intensive Care Unit (ICU) Setting [clinicaltrials:NCT00125398]Study of AQUAVAN® Injection (AQUAVAN; Fospropofol Disodium) for Sedation During Colonoscopy [clinicaltrials:NCT00125424]A Double-blind, Comparative Study in Patients With Gastric Ulcer to Evaluate the Efficacy of Combination Use of E0671 and Rabeprazole Sodium [clinicaltrials:NCT00125736]Effects of Combination Therapy With Alpha-1 Blocker (Bunazosin or Doxazosin) in the Treatment of Patients With Mild to Moderate Essential Hypertension [clinicaltrials:NCT00130156]A Phase 1 Open-Label Study of E7974 Administered on Days 1 and 15 of a 28-Day Cycle in Patients With Solid Malignancies [clinicaltrials:NCT00130169]clinicaltrials:NCT00132496E2007 Given as Adjunctive Therapy in Patients With Refractory Partial Seizures [clinicaltrials:NCT00144690]clinicaltrials:NCT00154063A Multicenter Comparative Trial of Zonisamide and Topiramate as Initial Monotherapy in Untreated Epilepsies [clinicaltrials:NCT00154076]A Study of E7070 in Patients With Gastric Cancer [clinicaltrials:NCT00165594]Randomized, Open, Parallel, Active Controlled Study on Fracture Prevention in Antiosteoporosis Treatment (OF Study) [clinicaltrials:NCT00165607]A Randomized, Open, Parallel, Optimal Injection Rate-Finding Study for E7337 in Dynamic CT of the Liver in Patients With Liver Disease [clinicaltrials:NCT00165620]A Phase II/III Clinical Study on Inhibitory Effects of E0167 on Recurrence of Hepatocellular Carcinoma [clinicaltrials:NCT00165633]clinicaltrials:NCT00165646A Multi-Center, Randomized, Double-Blind, Parallel Group Study With 3 Groups Receiving Placebo, 5 mg of E2020 and 10 mg of E2020 [clinicaltrials:NCT00165659]
source [clinicaltrials_vocabulary:source]
Eisai Inc. [clinicaltrials_resource:73f65fc9612e17a505f490571aa8adc5]
Bio2RDF identifier
73f65fc9612e17a505f490571aa8adc5
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:73f65fc9612e17a505f490571aa8adc5
organization [clinicaltrials_vocabulary:organization]
identifier
clinicaltrials_resource:73f65fc9612e17a505f490571aa8adc5
title
Eisai Inc.
@en
type
label
Eisai Inc. [clinicaltrials_resource:73f65fc9612e17a505f490571aa8adc5]
@en